Pathogen specific nucleic acid fragment and application thereof
US-2024352539-A1 · Oct 24, 2024 · US
US9758547B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9758547-B2 |
| Application number | US-201313848257-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 21, 2013 |
| Priority date | Mar 3, 2010 |
| Publication date | Sep 12, 2017 |
| Grant date | Sep 12, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Ligand functionalized substrates, methods of making ligand functionalized substrates, and methods of using functionalized substrates are disclosed.
Opening claim text (preview).
The invention claimed is: 1. An article comprising: an organic polymeric porous substrate having a coating on a surface thereof of a water soluble or water dispersible aminopolymer functionalized with guanidinyl groups, wherein the amino polymer is selected from the group consisting of polyethyleneimine, polyaminoamides, polyallylamine, polyvinylamine, polydimethylamine-epichlorohydrin-ethylenediamine, polyaminosiloxanes and dendrimers formed from polyamidoamine (PAMAM) and polypropylenimine. 2. The article of claim 1 wherein the aminopolymer functionalized with guanidinyl groups is of the formula: wherein R 2 is a H, C 1 -C 12 alkyl, C 5 -C 12 (hetero)aryl, or a residue of the polymer chain; each R 3 is independently H, C1-C12 alkyl, or C5-C12 (hetero)aryl, each R 4 is H, C 1 -C 12 alkyl or alkylene, C 5 -C 12 (hetero)aryl or (hetero)arylene, cyano, or —C(═NH)—N(R 2 )—Polymer, Polymer is the aminopolymer chain; and n is 1 or 2. 3. The article of claim 1 wherein the porous base substrate is a microporous base substrate. 4. The article of claim 1 wherein the porous base substrate is a nonwoven web. 5. The article of claim 1 wherein 0.1 to 100 mole percent of the available amino groups of the aminopolymer are functionalized with guanidinyl groups. 6. The article of claim 1 wherein the guanidinyl groups of the functionalized aminopolymer are pendent from the polymer chain. 7. The article of claim 1 wherein guanidinyl groups of the functionalized aminopolymer are in the aminopolymer chain. 8. The article of claim 1 , when contacted with a target a neutral or negatively charged biological species, a complex comprising the ligand-functionalized polymer and the target biological species is formed. 9. The article of claim 8 wherein said target biological species selected from biomacromolecules and microbiological species. 10. The article of claim 8 wherein said biomacromolecules are selected from proteins, enzymes, nucleic acids, and endotoxins. 11. The article of claim 8 wherein said biological species is selected from bacteria, viruses, cells, cell debris, and spores. 12. The article of claim 11 wherein the cells are selected from archaea, bacteria, and eucaryota. 13. The article of claim 8 wherein the biological species is derived from a cell culture or fermentation process. 14. The article of claim 8 wherein the amount of ligand-functionalized polymer relative to the amount of target biological species is 0.01% to 100% by weight. 15. The article of claim 1 wherein a portion of the amino groups of the ligand-functionalized polymer further comprise alkyl or acyl groups. 16. The article of claim 1 wherein the functionalized aminopolymer is crosslinked. 17. The article of claim 1 wherein the functionalized aminopolymer is uncrosslinked. 18. The article of claim 1 wherein the coating is grafted. 19. The article of claim 1 wherein the coating is ungrafted.
by a single or double bond to nitrogen · CPC title
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)} · CPC title
containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen · CPC title
Polyamides derived from alpha-amino carboxylic acids (C08L77/10 takes precedence) · CPC title
Polyamines · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.